Back to search

Article

Genomic ascertainment of<i>CHEK2</i>-related cancer predisposition

2024-08-08

Abstract excerpt

<h4>Purpose</h4> There is clear evidence that deleterious germline variants in CHEK2 increases risk for breast and prostate cancers; there is limited or conflicting evidence for other cancers. Genomic ascertainment was used to quantify cancer risk in CHEK2 germline pathogenic variant heterozygotes. <h4>Patients and Methods</h4> Germline CHEK2 variants were extracted from two exome-sequenced biobanks linked to the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d0b319b1-acb9-5a8d-8ebb-13a52a5d569c
DOI
10.1101/2024.08.07.24311613
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genomic ascertainment of<i>CHEK2</i>-related cancer predispositionDOI 10.1101/2024.08.07.24311613
Select a neighboring publication to make it the new centre.